TesoRx is a virtual pharmaceutical company developing and commercializing pharmaceutical products. The company engages in developing and commercializing pharmaceutical products. It develops TSX-002, an oral therapeutic testosterone formulation for use in testosterone deficiency in men. The company was incorporated in 2010 and is based in Menlo Park, California.

Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY.

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a rare and often chronic infection that can cause irreversible lung damage and can be fatal. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.

NuvOx Pharma develops a platform for drugs that upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ib ready).

A. Nattermann & Cie. GmbH engages in the production of over-the-counter and consumer health care drugs. Its products are sold to distribution firms of the Sanofi group. The company is headquartered in Cologne, Germany.

Servier Laboratories (doing business as Les Laboratories Servier) is a French private company located in Paris. The firm operates as a pharmaceutical company.\nThe company says this about itself: Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2020, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient's voice at the heart of its activities. A leader in cardiology, the ambition of the Servier Group is to become a recognized and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology and immuno-inflammatory, and neurodegenerative diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and\nother related life-threatening illnesses.

Sankyo Co., Ltd. engages in the manufacture and sale of pachinko and pachislot machines. It operates through the following segments: Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Others. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges and its related parts. The Pachislot Machines Business segment markets pachislot machines and related parts. The Ball Bearing Supply Systems segment sells pachinko and pachislot ball feeders, card system equipment, and parlor-related equipment. The Others segment comprises of mobile content service, real estate, golf club operations, and sells general molding products. The company was established on April 12, 1966 and is headquartered in Tokyo, Japan.

KT&G is the leading tobacco company in South Korea with annual sales of over $4 billion USD. KT&G was originally a government-owned monopoly but was privatized and today is publicly traded, competing for market share with other international tobacco firms such as Philip Morris International, British American Tobacco, and Japan Tobacco. KT&G's sales volume share was 62% of the Korean market in 2009. KT&G produces popular Korean cigarette brands such as The One, Indigo, Arirang, This, This Plus, Zest, Esse, Raison, and Lo Crux. It has been expanded outside Korea, especially through its superslims brand Esse in Russia and other eastern European markets. KT&G also owns significant subsidiaries such as Korea Ginseng Corporation, Yungjin Pharm (a pharmaceuticals company), and several bio ventures. Its headquarters are in Daejeon.

Fidia Farmaceutici SpA manufactures pharmaceutical products. The firm's platform technology level is the chemical modification, development, and manufacturing of state-of-the-art pharmaceuticals and medical devices based on hyaluronan covering therapeutic categories. The company was founded in 1946 and is headquartered in Abano Terme, Italy.

Imunon is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2. The company’s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications. Imunon also has two feasibility-stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.

Jiangxi Gannan Haixin Pharmaceutical Co., Ltd., established on 2001-12-31, Business scope includes pharmaceutical production and sales;food additives(Contains compound food additives),Pharmaceutical Packaging(BFSThree in one oral liquid plastic bottle,BFSThree-in-one polypropylene plastic ampoule,BFSThree-in-one polyethylene plastic ampoule,BFSThree-in-one inner-sealed polypropylene infusion bag,BFSThree-in-one inner-sealed polyethylene infusion bag(The above projects are operated with valid licenses),Chemical raw materials(except dangerous goods)of self-produced;Self-operated and agent import and export of various commodities and technologies and consulting services for import and export business(Except for goods subject to state trade management).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Daiichi Pharmaceutical Co. Ltd. manufactured pharmaceutical products. It used to make prescription drugs, OTC treatments and animal health products. The firm's prescription drugs included treatments for allergies, hypertension and stroke; it also has drugs in clinical trials. It was founded in 1915 and was located in Tokyo, Japan.

Shanghai Nanotechnology and Application National Engineering Research Center Co., Ltd., established on 2004-08-20, Business scope includes research and development of nanotechnology and related technologies,Production and sales of nano-related products,Technology development in the nanosphere,technology transfer,technical consulting,Technical Services,Investment in projects and products,account Serive. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Windtree Therapeutics (formerly Discovery Laboratories) is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant — and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree is focused initially on improving the management of respiratory distress syndrome (RDS) in premature infants and believes that its proprietary technology may make it possible, over time, to develop a pipeline of KL4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies.

Shanghai Keyan Biotechnology Co., Ltd., established on 2018-07-02, Business scope includes licensed projects:food business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engaged in technology development in the professional field of biotechnology,technology transfer,technical consulting,Technical Services,Business Consulting,nail service,Sales:cosmetic,Daily necessities,crafts,Gold and Silver Jewelry,Apparel and accessories,electronic product,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Korea Ginseng Corp. manufactures and supplies herbs. The firm offers ginseng based food products and beverages such as ginseng tea, capsules, and other related drinks. It has operations in China, Taiwan, Japan, and the United States. The company was founded on January 1, 1999 and is headquartered in Daejeon, Korea.